Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps

Plastic and Reconstructive Surgery

Volumn 113, Issue 7, 2004, Pages 2030-2036

  Wong, Michael S ^a,b   Erdmann, Deilev ^a   Sweis, Ranya ^a   Pöllmann, Christiane ^a   Farrar, Margaret ^a   Georgiade, Gregory S ^a   Levin, L Scott ^a   Olbrich, Kevin C ^a   Klitzman, Bruce ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; MYOCUTANEOUS FLAP; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECTUS ABDOMINIS MUSCLE; ANIMAL; BREAST RECONSTRUCTION; METABOLISM; PLASTIC SURGERY; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; GRAFT SURVIVAL; MAMMAPLASTY; RATS; RATS, SPRAGUE-DAWLEY; RECTUS ABDOMINIS; SURGICAL FLAPS; TIME FACTORS;

EID: 3242675308     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000122217.16985.52     Document Type: Article

References (29)

1. Holmström, H. The free abdominoplasty flap and its use in breast reconstruction. Scand. J. Plast. Reconstr. Surg. 13: 423, 1979.
2. Hartrampf, C. R., Scheflan, M., and Black, P. W. Breast reconstruction with a transverse abdominal island flap. Plast. Reconstr. Surg. 69: 216, 1982.
3. Restifo, R. J., Ahmed, S. S., Isenberg, J. S., and Thomson, J. G. Timing, magnitude, and utility of surgical delay in the TRAM flap: I. Animal studies. Plast. Reconstr. Surg. 99: 1211, 1997.
4. Restifo, R. J., Ward, B. A., and Scoutt, L. M. Timing, magnitude, and utility of surgical delay in the TRAM flap: II. Clinical studies. Plast. Reconstr. Surg. 99: 1217, 1997.
5. Taylor, G. I., Corlett, R. J., Caddy, C. M., and Zelt, R. G. An anatomic review of the delay phenomenon: II. Clinical applications. Plast. Reconstr. Surg. 89: 408, 1992.
6. Özgentas, H. E., Shenaq, S., and Spira, M. Study of the delay phenomenon in the rat TRAM flap model. Plast. Reconstr. Surg. 94: 1018, 1994.
7. Poole, T. J., Finkelstein, E. B., and Cox, C. M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn. 220: 1, 2001.
8. Forootan, S. S., Ke, Y., Jones, A. S., and Helliwell, T. R. Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue. Oral Oncol. 36: 437, 2000.
9. Li, Z., Shimada, Y., Uchida, S., et al. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int. J. Oncol. 17: 453, 2000.
10. Sugamoto, T., Tanji, N., Sata, K., et al. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: Correlation with neovascularization. Anticancer Res. 21: 77, 2001.
11. Compagni, A., Wilgenbus, P., Impagnatiello, M. A., Cotten, M., and Christofori, G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res. 60: 7163, 2000.
12. Rofstad, E. K., and Halsor, E. F. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 60: 4932, 2000.
13. Codner, M. A., and Bostwick, J., III. The delayed TRAM flap. Clin. Plast. Surg. 25: 183, 1998.
14. Codner, M. A., Bostwick, J., III, Nahai, F., Bried, J. T., and Eaves, F. F. TRAM flap vascular delay for high-risk breast reconstruction. Plast. Reconstr. Surg. 96: 1615, 1995.
15. Erdmann, D., Sundin, B. M., Moquin, K, J., Young, H., and Georgiade, G. S. Delay in unipedicled TRAM flap reconstruction of the breast: A review of 76 consecutive cases. Plast. Reconstr. Surg. 110: 762, 2002.
16. Arnez, A. M., Bajec, J., Bardsley, A. F., Scamp, T., and Webster, M. H. C. Experience with 50 free TRAM flap breast reconstructions. Plast. Reconstr. Surg. 87: 470, 1991.
17. Elliott, L. F., Eskenazi, L., Beegle, P. H., Podres, P. E., and Drazan, L. Immediate TRAM flap breast reconstruction: 128 consecutive cases. Plast. Reconstr. Surg. 92: 217, 1993.
18. Grotting, J. C., Urist, M. M., Maddox, W. A., and Vasconez, L. O. Conventional TRAM flap versus free microsurgical TRAM flap for immediate breast reconstruction. Plast. Reconstr. Surg. 83: 828, 1989.
19. Schusterman, M. A., Kroll, S. S., Miller, M. J., et al. The free transverse rectus abdominis musculocutaneous flap for breast reconstruction: One center's experience with 211 consecutive cases. Ann. Plast. Surg. 32: 234, 1994.
20. Restifo, F. J., Ahmed, S. S., Rosser, J., et al. TRAM flap perforator ligation and the delay phenomenon: Development of an endoscopic/laparoscopic delay procedure. Plast. Reconstr. Surg. 101: 1503, 1998.
21. Scheufler, O., Andresen, R., Kirsch, A., Banzer, D., and Vaubel, E. Clinical results of TRAM flap delay by selective embolization of the deep inferior epigastric arteries. Plast. Reconstr. Surg. 105: 1320, 2000.
22. Karacaoglu, E., Yuksel, F., Turan, S. O., and Zienowicz, R. J. Chemical delay: An alternative to surgical delay experimental study. Ann. Plast. Surg. 49: 73, 2002.
23. Cross, M. J., and Claesson-Welsh, L. FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22: 201, 2001.
24. Nugent, M. A., and Iozzo, R. V. Fibroblast growth factor-2. Int. J. Biochem. Cell. Biol. 32: 115, 2000.
25. Okada-Ban, M., Thiery, J. P., and Jouanneau, J. Fibroblast growth factor-2. Int. J. Biochem. Cell. Biol. 32: 263, 2000.
26. Gospodarowicz, D. Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem. 250: 2515, 1975.
27. Friesel, R., and Maciag, T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82: 748, 1999.
28. Delrieu, I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism. FEBS Lett. 468: 6, 2000.
29. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D. B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18: 26, 1997.